Home » Newsletters » BioWorld Science

BioWorld Science

March 4, 2021

View Archived Issues

New phase I/II study of bintrafusp alfa with M-9241 and docetaxel in metastatic prostate cancer

Movement strengthens bones, and immunity

Atherosclerosis precedes clonal hematopoiesis

Ascendis initiates phase III trial of TransCon PTH for hypoparathyroidism

PIPE-307 enters phase I development as potential treatment of multiple sclerosis

Cancer-associated fibroblasts influence GIST progression and metastasis through PDGFC secretion

GcgR antagonist enhances functional beta-cell mass and glycemic control in type 1 diabetes

Topline data from BRAVE-AA2 phase III study of baricitinib in severe alopecia areata

MediciNova discontinues development of vaccine for COVID-19

FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19

Guangdong Xiangxue Life Sciences patents TCRs targeting AFP-derived short peptide

New IRAK-4 inhibitors identified at Bristol Myers Squibb

Alkermes presents new mu-opioid receptor agonists

Ankh Life Sciences describes new anticancer compounds

Xentria submits IND application to the FDA for XTMAB-16 as treatment of sarcoidosis

Arbutus Biopharma identifies HBsAg secretion inhibitors

Wellmarker Bio receives phase I study approval for WM-S1-030 in Australia

Galapagos reports interim data from safety studies of filgotinib

Positive topline data from phase II program of AZR-MD-001 in Meibomian gland dysfunction

PHA-022121 shows promise for treating hereditary angioedema

Benralizumab achieves OCS elimination or reduction in OCS-dependent asthmatics

MiR-939-5p, tumor suppressor and potential therapeutic target in TNBC

FDA clears IND for pilot study of NVD-003 for congenital pseudarthrosis of the tibia

FDA clears initiation of phase I study of DT-2216 for solid tumors

COVID-eVax vaccine enters phase I/II study

CFI-402257 plus paclitaxel shows manageable safety in HER2-negative breast cancer patients

Nuformix reports preclinical data on NXP-002 in combination therapy for IPF

"Confounders" could be bountiful harvest rather than nuisance in epigenomics

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...